Comparison of patients with biopsy positive and negative primary angiitis of the central nervous system.

Primary angiitis of the central nervous system biopsy cerebral vasculitis

Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
06 Oct 2023
Historique:
received: 22 06 2023
revised: 08 09 2023
accepted: 27 09 2023
medline: 7 10 2023
pubmed: 7 10 2023
entrez: 6 10 2023
Statut: aheadofprint

Résumé

There is limited evidence on when to obtain a central nervous system (CNS) biopsy in suspected primary angiitis of the central nervous system (PACNS). Our objective was to identify which clinical and radiological characteristics were associated with a positive biopsy in PACNS. From the multicenter retrospective Cohort of Patients with Primary Vasculitis of the CNS (COVAC), we included adults with PACNS based on a positive CNS biopsy or otherwise unexplained intracranial stenoses with additional findings supportive of vasculitis. Baseline findings were compared between patients with a positive and negative biopsy using logistic regression models. 200 patients with PACNS were included, among which a biopsy was obtained in 100 (50%) and was positive in 61 (31%). Patients with a positive biopsy were more frequently female (OR 2.90, 95% CI 1.25-7.10, p = 0.01) and more often presented with seizures (OR 8.31, 95% CI 2.77-33.04, p < 0.001) or cognitive impairment (OR 2.58, 95% CI 1.11-6.10, p = 0.03). On imaging, biopsy positive patients more often had non-ischemic parenchymal or leptomeningeal gadolinium enhancement (OR 52.80, 95% CI 15.72-233.06, p < 0.001) or ≥ 1 cerebral microbleed (OR 8.08, 95% CI 3.03-25.13, p < 0.001), and less often had ≥ 1 acute brain infarct (OR 0.02, 95% CI 0.004-0.08, p < 0.001). In the multivariable model, non-ischemic parenchymal or leptomeningeal gadolinium enhancement (aOR 8.27, 95% CI 1.78-38.46), p < 0.01) and absence of ≥ 1 acute brain infarct (aOR 0.13, 95% CI 0.03-0.65, p = 0.01) were significantly associated with a positive biopsy. Baseline clinical and radiological characteristics differed between biopsy positive and negative PACNS. These results may help physicians individualize the decision to obtain a CNS biopsy in suspected PACNS.

Identifiants

pubmed: 37802919
pii: 7295624
doi: 10.1093/rheumatology/kead542
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

Xavier Ayrignac (X)
Hélène Zéphir (H)
Antoine Néel (A)
Arsène Mekinian (A)
Laurent Létourneau-Guillon (L)
Laurent Derex (L)
Mathieu Gerfaud-Valentin (M)
Véronique Quénardelle (V)
Laurent Daniel Kremer (LD)
Cédric Gollion (C)
David Weisenburger (D)
Matthieu Vautier (M)
Stéphanie Machado (S)
Adil Maarouf (A)
Lisa Humbertjean (L)
Stéphane Vannier (S)
Christian Denier (C)
Barbara Casolla (B)
Saskia Bresch (S)
Michael Levraut (M)
Hassan Hosseini (H)
Nicolas Lambert (N)
Marie Subreville (M)
Thomas Papo (T)
Igor Sibon (I)
Chloé Comarmond-Ortoli (C)
Mikael Mazighi (M)
Philippe Kerschen (P)
Denis Sablot (D)
Marie Gaudron (M)
Alexandra Audemard-Verger (A)
Fabienne Closs-Prophette (F)
Jérémie Papassin (J)
Laure Daelman (L)
Mathieu Zuber (M)
Michael Obadia (M)
Fernando Pico (F)
Paul Cantagrel (P)
Julie Graveleau (J)
Louis Poncet-Megemont (L)
Thomas Ancel (T)

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Ahmad Nehme (A)

Neurology, Université Caen-Normandie, CHU Caen-Normandie, Caen, France.

Caroline Arquizan (C)

Neurology, CHU de Montpellier, Montpellier, France.

Alexis Régent (A)

Internal Medicine, Université Paris-Cité, Hôpital Cochin, AP-HP, Paris, France.

Clothilde Isabel (C)

Neurology, GHU Paris, Paris, France.

Nelly Dequatre (N)

Neurology, CHU Lille, Lille, France.

Benoit Guillon (B)

Neurology, CHU Nantes, Nantes, France.

Jean Capron (J)

Neurology, Hôpital Saint-Antoine, AP-HP, Paris, France.

Olivier Detante (O)

Université Grenoble Alpes, INSERM, U1216, Neurology, CHU Grenoble Alpes, Grenoble Institute Neurosciences, Grenoble, France.

Sylvain Lanthier (S)

Neurology, Hôpital du Sacré-cœur de Montréal, Quebec, Canada.

Alexandre Y Poppe (AY)

Neurology, Centre hospitalier de l'Université de Montréal, Quebec, Canada.

Grégoire Boulouis (G)

Radiology, CHU Tours, Tours, France.

Sophie Godard (S)

Neurology, CHU Angers, Angers, France.

Benjamin Terrier (B)

Internal Medicine, Université Paris-Cité, Hôpital Cochin, AP-HP, Paris, France.

Christian Pagnoux (C)

Vasculitis Clinic, Mount Sinai Hospital, University of Toronto, Ontario, Canada.

Achille Aouba (A)

Université Caen-Normandie, Internal Medicine, CHU Caen-Normandie, Caen, France.

Emmanuel Touzé (E)

Neurology, Université Caen-Normandie, CHU Caen-Normandie, Caen, France.

Hubert de Boysson (H)

Université Caen-Normandie, Internal Medicine, CHU Caen-Normandie, Caen, France.

Classifications MeSH